Clinical Trials
20 trialsNCT05755646 2026-05-06
WIn-HFS
University Hospital Tuebingen
Phase NA Completed
NCT05165069 2026-02-02
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3 Active not recruiting
NCT07375446 2026-01-29
Traditional Chinese Medicine Hand-Foot Soak for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome
Peking University Third Hospital
Not yet recruiting
NCT07177560 2025-09-17
DICLO-HFS
Gazi University
Completed
NCT07114627 2025-08-11
ESCAPE
Erasmus Medical Center
Recruiting
NCT06602167 2024-12-12
Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome
Affiliated Hospital of Qinghai University
Phase NA Recruiting
NCT06583369 2024-09-04
The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT06441513 2024-06-04
The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome
Peking University Third Hospital
Phase NA Unknown
NCT05641246 2024-01-03
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine
German University in Cairo
Phase 2 Completed
NCT04979078 2023-06-18
DermLight
Jessa Hospital
Phase NA Recruiting
NCT05327751 2022-04-14
HFS
Tanta University
Phase 3 Unknown
NCT00751101 2020-10-05
Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
University of California, San Francisco
Phase 2 Terminated
NCT02794493 2019-07-25
Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
China-Japan Friendship Hospital
Phase 3 Completed
NCT00992706 2019-05-15
F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer
Swiss Cancer Institute
Phase 3 Completed
NCT03173365 2019-01-09
BRIMOCAN
Heinrich-Heine University, Duesseldorf
Phase 2 Terminated
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00486213 2015-09-24
Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
National Cancer Centre, Singapore
Phase 3 Terminated
NCT01291628 2012-01-19
Prevention of Capecitabine Induced Hand and Foot Syndrome
Rabin Medical Center
Phase NA Unknown
NCT00248248 2011-10-12
DOXIL for Consolidation Therapy in Ovarian Cancer.
Southeastern Gynecologic Oncology
Phase 2 Completed